trial

Substance Misuse To Psychosis for Stimulants

NCTId NCT03485417
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2, Phase 3 · Completed
Enrollment 165 (actual)
Sponsored by The University of Hong Kong
Primary completion 2024-05-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2, Phase 3
Status
Completed
Enrollment
165 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2019-06-01
Primary completion
2024-05-31
Eligibility
ALL · 16 Years · 50 Years

Interventions & indications

Drugs
AripiprazolePaliperidone

Sponsors

The University of Hong KongLead Sponsor
Queen Mary Hospital, Hong KongCollaborator
North District Hospital, Hong KongCollaborator

Investigators

1
albert KK Chung, DrPrincipal Investigator

Sites

1 total
Hong Kong, Hong Kong

Linked catalysts

1
Substance Misuse To Psychosis for Stimulants — primary completion2024-05-31

Facts & assertions

4 sourced
Enrollment
165
Phase
PHASE2,PHASE3
Primary Completion Date
2024-05-31
Status
COMPLETED
relationships
The graph out of here
drug
Aripiprazole
drug
Paliperidone
drug
lead_sponsor
The University of Hong Kong
company
collaborator
Queen Mary Hospital, Hong Kong
company
North District Hospital, Hong Kong
company
indication
Pharmacotherapy
indication
Stimulant Dependence
indication
Psychotic Disorders
indication
investigator
albert KK Chung, Dr
person